This leads to improved clearance of alpha‐synuclein, a protein implicated in the pathogenesis of AD (causes increased tau hyperphosphorylation via GSK‐3β) [57], and Parkinson's disease (PD) [78]. Here, GSK3B is linked to Parkinson disease.